Fitzgerald JL. Mapping the experience of drug dealing risk environments: an ethnographic case study. Int J Drug Policy. 2009;20(3):261–9.
Hien NT, Giang LT, Binh PN, Wolffers I. The social context of HIV risk behaviour by drug injectors in Ho Chi Minh City. Vietnam AIDS Care. 2000;12(4):483–95.
Ivsins A, Roth E, Benoit C, Fischer B. Crack pipe sharing in context: how sociostructural factors shape risk practices among noninjection drug users. Contemp Drug Probl. 2013;40(4):481–503.
Lazarus L, Chettiar J, Deering K, Nabess R, Shannon K. Risky health environments: women sex workers’ struggles to find safe, secure and non-exploitative housing in Canada’s poorest postal code. Soc Sci Med. 2011;73(11):1600–7.
Ramos R, Ferreira-Pinto JB, Brouwer KC, Ramos ME, Lozada RM, Firestone-Cruz M, et al. A tale of two cities: social and environmental influences shaping risk factors and protective behaviors in two Mexico–US border cities. Health Place. 2009;15(4):999–1005.
Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193–201.
Shannon K, Strathdee SA, Shoveller J, Rusch M, Kerr T, Tyndall MW. Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health. 2009;99(4):659–65.
Bardwell G, Strike C, Altenberg J, Barnaby L, Kerr T. Implementation contexts and the impact of policing on access to supervised consumption services in Toronto, Canada: a qualitative comparative analysis. Harm Reduc J. 2019;16(1):30.
Kerr T, Mitra S, Kennedy MC, McNeil R. Supervised injection facilities in Canada: past, present, and future. Harm Reduc J. 2017;14(1):28.
Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: What has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.
Wolf J, Linssen L, de Graaf I. Drug consumption facilities in the Netherlands. J Drug Issues. 2003;33(3):649–61.
Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29(2):126–30.
Bardwell G, Strike C, Mitra S, Scheim A, Barnaby L, Altenberg J, et al. “That’s a double-edged sword”: exploring the integration of supervised consumption services within community health centres in Toronto. Canada Health Place. 2020;61:102245.
Krusi A, Small W, Wood E, Kerr T. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. AIDS Care. 2009;21(5):638–44.
Boyd S. From witches to crack moms: women, drug law, and policy. Durham: Carolina Academic Press; 2015.
Campbell ND, Herzberg D. Gender and critical drug studies: an introduction and an invitation. Contemp Drug Probl. 2017;44(4):251–64.
Schäffer D, Stöver H, Weichert L. Drug consumption rooms in Europe: models, best practice and challenges. Amsterdam: European Harm Reduction Network; 2014.
Boyd J, Lavalley J, Czechaczek S, Mayer S, Kerr T, Maher L, et al. “Bed Bugs and Beyond”: an ethnographic analysis of North America’s first women-only supervised drug consumption site. Int J Drug Policy. 2020;66:102733.
Speed KA, Gehring ND, Launier K, O’Brien D, Campbell S, Hyshka E. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities. Harm Reduc J. 2020;17(1):72.
Cortina S, Kennedy MC, Dong H, Fairbairn N, Hayashi K, Milloy MJ, et al. Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver. Canada Drug Alcohol review. 2018;37(5):645–52.
Strathdee SA, Navarro JR. Commentary on Salmon et al. (2010): the case for safer inhalation facilities–waiting to inhale. Addiction. 2010;105(4):684–5.
Voon P, Ti L, Dong H, Milloy MJ, Wood E, Kerr T, et al. Risky and rushed public crack cocaine smoking: the potential for supervised inhalation facilities. BMC Public Health. 2016;16:476.
Jozaghi E. Vancouver area network of drug users. A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada. Harm Reduc J. 2014;1(1):30.
Foreman-Mackey A, Bayoumi AM, Miskovic M, Kolla G, Strike C. “It’s our safe sanctuary”: experiences of using an unsanctioned overdose prevention site in Toronto, Ontario. Int J Drug Policy. 2019;73:135–40.
McNeil R, Kerr T, Lampkin H, Small W. “We need somewhere to smoke crack”: an ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada. Int J Drug Policy. 2015;26(7):645–52.
Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313(7054):402.
Novak SP, Kral AH. Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States. J Addict Dis. 2011;30(3):248–57.
Pizzey R, Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation. Harm Reduc J. 2008;5(1):24.
Stöver HJ, Schäffer D. SMOKE IT! Promoting a change of opiate consumption pattern—from injecting to inhaling. Harm Reduc J. 2014;11(1):18.
Ivsins A, Marsh S. Exploring what shapes injection and non-injection among a sample of marginalized people who use drugs. Int J Drug Policy. 2018;57:72–8.
Reynolds A, Leonard L, Germain A. What women and men who smoke crack have to say about HIV and hepatitis C prevention: implications for policy and program development. Ottawa: Department of Epidemiology and Community Medicine, University of Ottawa; 2011.
Alambyan V, Pace J, Miller B, Cohen ML, Gokhale S, Singh G, et al. The emerging role of inhaled heroin in the opioid epidemic: a review. JAMA Neurol. 2018;75(11):1423–34.
Maher L, Swift W, Dawson M. Heroin purity and composition in Sydney, Australia. Drug Alcohol Rev. 2001;20(4):439–48.
Sargent P, Maher L, Higgs P, Crofts N. Initiation into injecting drug use of young Indo-Chinese people. Health Promot J Aust. 2001;12:242–7.
Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction. 1999;94(1):71–82.
Buxton JA, Sebastian R, Clearsky L, Angus N, Shah L, Lem M, et al. Chasing the dragon—characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia. Harm Reduc J. 2011;8(1):3.
BC Coroners Service. Illicit drug toxicity deaths in BC knowledge update: Mode of consumption 2020. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/mode-of-consumption.pdf.
Thiblin I, Eksborg S, Petersson A, Fugelstad A, Rajs J. Fatal intoxication as a consequence of intranasal administration (snorting) or pulmonary inhalation (smoking) of heroin. Forensic Sci Int. 2004;139(2):241–7.
Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women’s involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend. 2000;58(3):227–36.
Shannon K, Rusch M, Morgan R, Oleson M, Kerr T, Tyndall MW. HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs. Subst Use Misuse. 2008;43(3–4):521–34.
Johnson J, Malchy L, Mulvogue T, Moffat B, Boyd S, Buxton J, et al. Lessons learned from the SCORE Project: A document to support outreach and education related to safer crack use. Vancouver: Nursing and Health Behaviour Research Unit, University of British Columbia; 2008.
Brecht ML, O’Brien A, von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav. 2004;29(1):89–106.
DeBeck K, Buxton J, Kerr T, Qi J, Montaner J, Wood E. Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder. Subst Abuse Treat Prev Policy. 2011;6:4.
DeVerteuil G. Conceptualizing violence for health and medical geography. Soc Sci Med. 2015;133:216–22.
Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ. 2004;63(3):253–64.
Shoveller JA, Johnson JL. Risky groups, risky behaviour, and risky persons: dominating discourses on youth sexual health. Crit Public Health. 2006;16(1):47–60.
Farmer P. An anthropology of structural violence. Curr Anthropol. 2004;45(3):305–25.
Bungay V, Johnson JL, Varcoe C, Boyd S. Women’s health and use of crack cocaine in context: structural and “everyday” violence. Int J Drug Policy. 2010;21(4):321–9.
Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911–21.
Boyd J, Collins AB, Mayer S, Maher L, Kerr T, McNeil R. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada. Addiction. 2018;66:5.
Collins AB, Boyd J, Damon W, Czechaczek S, Krusi A, Cooper H, et al. Surviving the housing crisis: social violence and the production of evictions among women who use drugs in Vancouver, Canada. Health Place. 2018;51:174–81.
Butters J, Erickson PG. Meeting the health care needs of female crack users: a Canadian example. Women Health. 2003;37(3):1–17.
Bardwell G, Fleming T, McNeil R, Boyd J. Women’s multiple uses of an overdose prevention technology to mitigate risks and harms within a supportive housing environment: a qualitative study. BMC Womens Health. 2021;21(1):51.
Allingham J. Is the fentanyl situation an overdose crisis or a poisoning crisis?: CBC News; 2017. https://www.cbc.ca/news/canada/british-columbia/overdose-fentanyl-1.4269917.
British Columbia Coroners Service. Fentanyl-detected illicit drug toxicity deaths: January 1, 2012 to May 31, 2020. 2020.
Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–11.
Fleiz C, Arredondo J, Chavez A, Pacheco L, Segovia LA, Villatoro JA, et al. Fentanyl is used in Mexico’s northern border: current challenges for drug health policies. Addiction. 2020;115(4):778–81.
BC Coroners Service. Illicit drug toxicity deaths in BC, January 1 2010–May 31, 2020 2020. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdf.
Lavalley J, Kastor S, Valleriani J, McNeil R. Reconciliation and Canada’s overdose crisis: responding to the needs of Indigenous Peoples. CMAJ. 2018;190(50):E1466–7.
First Nations Health Authority. First Nations in BC and the overdose crisis: COVID-19 pandemic sparks surge in overdose deaths 2020. https://www.fnha.ca/Documents/FNHA-First-Nations-in-BC-and-the-Overdose-Crisis-Infographic.pdf.
BC Coroners Service. Illicit drug overdose deaths in BC: Findings of coroners’ investigations 2018. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicitdrugoverdosedeathsinbc-findingsofcoronersinvestigations-final.pdf.
Bardwell G, Kerr T, McNeil R. The opioid overdose epidemic and the urgent need for effective public health interventions that address men who use drugs alone. Am J Mens Health. 2019;13(3):1557988319859113.
Collins AB, Bardwell G, McNeil R, Boyd J. Gender and the overdose crisis in North America: moving past gender-neutral approaches in the public health response. Int J Drug Policy. 2019;69:43–5.
Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. Reprod Health Matters. 2008;16(31):168–81.
Iversen J, Page K, Madden A, Maher L. HIV, HCV, and health-related harms among women who inject drugs: implications for prevention and treatment. J Acquir Immune Defic Syndr. 2015;69(Suppl 201):S176–81.
City of Surrey. City of Surrey: City profile 2016. https://www.surrey.ca/files/Neighbourhood-Profile-City-of-Surrey.pdf.
Kirby S, Greaves L, Reid C. Experience, research, social change: methods beyond the mainstream. Peterborough: Broadview Press; 2006.
Lawson AK, Marsh EE. Hearing the silenced voices of underserved women: the role of qualitative research in gynecologic and reproductive care. Obstet Gynecol Clin N Am. 2017;44(1):109–20.
Hesse-Biber S, Leavy P. The practice of qualitative research. Thousand Oaks: Sage; 2006.
Johnson GA, Vindrola-Padros C. Rapid qualitative research methods during complex health emergencies: a systematic review of the literature. Soc Sci Med. 1982;2017(189):63–75.
Schwartz D. Visual ethnography: USING photography in qualitative research. Qual Soc. 1989;12(2):119–54.
Close H. The use of photography as a qualitative research tool. Nurse Res. 2007;15(1):27–36.
Creswell JW, Miller DL. Determining validity in qualitative inquiry. Theory Int Pract. 2000;39(3):124–30.
Wray N, Markovic M, Manderson L. “Researcher Saturation”: the impact of data triangulation and intensive-research practices on the researcher and qualitative research process. Qual Health Res. 2007;17(10):1392–402.
Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. Los Angeles: Sage; 2015.
Bergin M. NVivo 8 and consistency in data analysis: reflecting on the use of a qualitative data analysis program. Nurse Res. 2011;18(3):6–12.
Handlovsky IE, Bungay V, Johnson J, Phillips JC. The process of safer crack use among women in Vancouver’s downtown eastside. Qual Health Res. 2012;23(4):450–62.
Persaud S, Tzemis D, Kuo M, Bungay V, Buxton JA. Controlling chaos: the perceptions of long-term crack cocaine users in Vancouver, British Columbia, Canada. J Addict. 2013;2013:851840.
Bourque S, Pijl EM, Mason E, Manning J, Motz T. Supervised inhalation is an important part of supervised consumption services. Can J Public Health. 2019;110(2):210–5.
Bardwell G, Kerr T, Boyd J, McNeil R. Characterizing peer roles in an overdose crisis: preferences for peer workers in overdose response programs in emergency shelters. Drug Alcohol Depend. 2018;190:6–8.
Dell CA, Kilty JM. The creation of the expected Aboriginal woman drug offender in Canada: exploring relations between victimization, punishment, and cultural identity. Int Rev Victimol. 2012;19(1):51–68.
Lewis R, Sharp E, Remnant J, Redpath R. ‘Safe Spaces’: experiences of feminist women-only space. Soc Res Online. 2015;20(4):105–18.
Kolla G, Strike C. Practices of care among people who buy, use, and sell drugs in community settings. Harm Reduct J. 2020;17(1):27.
Small W, Shoveller J, Moore D, Tyndall M, Wood E, Kerr T. Injection drug users’ access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res. 2011;21(6):743–56.
Duncan T, Sebar B, Lee J, Duff C. Mapping the spatial and affective composition of care in a drug consumption room in Germany. Soc Cult Geogr. 2019;6:1–20.
Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Subst Use Misuse. 1998;33(11):2323–51.
Fairbairn N, Small W, Shannon K, Wood E, Kerr T. Seeking refuge from violence in street-based drug scenes: Women’s experiences in North America’s first supervised injection facility. Soc Sci Med. 2008;67(5):817–23.
Small W, Moore D, Shoveller J, Wood E, Kerr T. Perceptions of risk and safety within injection settings: injection drug users’ reasons for attending a supervised injecting facility in Vancouver, Canada. Health Risk Soc. 2012;14(4):307–24.
Bardwell G, Collins AB, McNeil R, Boyd J. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions? Harm Reduct J. 2017;14(1):77.
Chu SKH, Kazatchkine C. Gendering the scene: women, gender-diverse people, and harm reduction in Canada. Toronto: Canadian HIV/AIDS Legal Network; 2020.
Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. “I inject less as I have easier access to pipes”: injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy. 2008;19(3):255–64.
McKnight C, Des Jarlais DC. Being “hooked up” during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82–8.
Bardwell G. The impact of risk environments on LGBTQ2S adults experiencing homelessness in a mid-sized Canadian city. J Gay Lesbian Soc Serv. 2019;31(1):53–64.
Yu V. Shelter and transitional housing for transgender youth. J Gay Lesbian Ment Health. 2010;14(4):340–5.
Ecker J, Aubry T, Sylvestre J. A review of the literature on LGBTQ adults who experience homelessness. J Homosex. 2019;66(3):297–323.